Want to lower LDL Cholesterol further, add Evolocumab & PCSK9 Inhibitors Dr. Kamal Kant Kohli Kohli24 Oct 2017 8:00 PM ISTPatients who need additional lowering of low‐density lipoprotein‐cholesterol (LDL‐C) despite statin therapy may benefit from additional lipid‐lowering...
Evolocumab approved to Prevent Heart Attack And Stroke Dr. Kamal Kant Kohli Kohli3 Dec 2017 7:30 PM ISTU.S. Food and Drug Administration (FDA) approved Evolocumab as the first PCSK9 inhibitor to prevent heart attacks, strokes and coronary...
High dose Statins more effectively reduce cardiovascular events Medha Baranwal Baranwal15 May 2018 8:30 PM ISTHigh-dose as compared with low-dose pitavastatin therapy helped in significant reduction of cardiovascular events in Japanese patients with stable...
Novel PCSK9 inhibitor, Inclisiran causes significant reduction of atherogenic lipoprotein Medha Baranwal Baranwal19 May 2018 8:25 PM ISTInclisiran, a small interfering RNA (siRNA) that inhibits proprotein convertase subtilisin kexin type 9 (PCSK9), produces significant and prolonged...
New JAS Guideline for Treatment and Diagnosis of Familial Hypercholesterolemia Medha Baranwal Baranwal23 Jun 2018 7:06 PM ISTThe Japan Atherosclerosis Society has released new guidelines for diagnosis and treatment of familial hypercholesterolemia (FH). The guidelines are...
Initiating Statin therapy : What all to be considered Dr. Kamal Kant Kohli Kohli15 July 2018 7:04 PM ISTStatins are backbone for treatment of Dyslipedemia but before initiating Statins ,clinicians must first determine the patient’s risk of having a...
Lower the LDL cholesterol level, lower is the risk to heart : JAMA Medha Baranwal Baranwal5 Aug 2018 8:28 PM ISTIn a new study Researchers have found that lower the LDL level, lower is the risk to the heart. Therefore there is no need to be scared of lowering...
LDL levels above 160 tied to CVD mortality even in low risk patients Medha Baranwal Baranwal21 Aug 2018 8:28 PM ISTLDL (low-density lipoprotein) levels above 160 mg/dL in the patients otherwise deemed at low risk for cardiovascular disease (CVD) face a 50% to 80%...
Is very low LDL-Cholesterol level safe- Check it out Hina Zahid8 Jan 2019 8:28 PM ISTLow-density Lipoprotein Cholesterol (LDL-C) is a known risk factor for cardiovascular diseases and there is sufficient evidence that supports a linear...
Triglycerides Paradox-Higher Triglycerides better for elderly, concludes new study Hina Zahid5 Feb 2019 8:28 PM ISTIt seems to be a Triglycerides Paradox for the super-elderly- the higher -the better. These were the results recently concluded by a recent study that...
FDA approves new PCSK9 inhibitor to lower LDL Cholesterol and CVD risk Dr. Kamal Kant Kohli Kohli27 April 2019 12:01 PM ISTFDA has approved new PCSK9 inhibitor, alirocumab for lowering LDL Cholesterol and CVD risk.The U.S. Food and Drug Administration (FDA) has approved...
High residual inflammatory risk, low LDL-C linked to higher death, heart attack risk after PCI Medha Baranwal Baranwal17 May 2019 8:28 PM ISTIt is very important to understand that inflammation does play a role in myocardial infarction is the message of a new study.Persistent high residual...
